Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial

Abroad (travel likely)RecruitingPHASE1

Conditions

Spinal Cord Injury · Safety · Clinical Trials · Efficacy · Induced Pluripotent Stem Cells · Human Motor Neuron Progenitor · Transplantation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Limin Rong, prof and M.D) · ronglm@mail.sysu.edu.cn · 02085253333

Study leads

Limin Rong, prof and M.D
Principal Investigator
Third Affiliated Hospital, Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury

Spinal Cord Injury

Abroad (travel likely)RecruitingPHASE1

Saint Paul, United States

Testosterone and Neural Function

Spinal Cord Injury

Abroad (travel likely)RecruitingEARLY_PHASE1

The Bronx, United States

Innovative Brain-Computer Interface for People With Spinal Cord Injury

Spinal Cord Injury · Tetraplegia C1-C4 · Quadriplegia

Abroad (travel likely)Recruiting

Utrecht, Netherlands

Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait

Spinal Cord Injury

Abroad (travel likely)Recruiting

Zurich, Switzerland